Temasek leads Tropic Biosciences' US$28.5m Series B funding round

Singapore

BIOTECH startup Tropic Biosciences, which develops high-performance varieties of tropical crops, on Thursday said it has raised US$28.5 million in a Series B round of funding led by Singapore investment firm Temasek Holdings, bringing its total equity funding raised to US$40 million.

The equity round is joined by new investors including Sumitomo Corporation Europe, Genoa Ventures, Agronomics and Skyviews Life Science. Existing investors Tekfen Ventures, Emerald Technology Ventures, Bits x Bites, and the UK Science & Innovation Seed Fund also participated in the round.